{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:03:10Z","timestamp":1749060190844},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To study whether esophageal FDG activity changes by time of mid-course of fractionated radiotherapy (RT), and whether these changes are associated with radiation esophagitis in patients with non-small cell lung cancer (NSCLC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Fifty patients with stage I-III NSCLC were enrolled prospectively and, all received \u226560\u00a0Gy RT. FDG-PET\/CT scans were acquired prior to, and during-RT after delivery of 45\u00a0Gy. Normalized standardized uptake values (NSUV), defined by the esophageal maximum SUV relative to intravascular background level in the aortic arch, were sampled in the esophagus at the level of the primary tumor, sternal notch, aortic arch, carina, and gastro-esophageal junction. Symptomatic radiation esophagitis was defined as an event.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Compared to baseline, esophageal NSUV increased significantly during-RT at the level of the primary tumor (1.09\u2009\u00b1\u20090.05 vs.1.28\u2009\u00b1\u20090.06, p\u2009=\u20090.001), but did not change at other levels in the esophagus. 16 patients had radiation esophagitis events and these patients had significantly higher during-RT to baseline NSUV ratios than those without esophagitis (1.46\u2009\u00b1\u20090.12, 95% CI 1.20-1.71; vs. 1.11\u2009\u00b1\u20090.05, 95% CI 1.01-1.21, p\u2009=\u20090.002). Maximum esophageal dose (p\u2009=\u20090.029), concurrent chemotherapy (p\u2009=\u20090.022) and esophageal FDG PET NSUV ratio (during-RT to baseline, p\u2009=\u20090.007), were independent factors associated with esophagitis and area under curves (AUC) were 0.76, 0.70 and 0.78, respectively. Combining esophageal maximum dose and FDG PET NSUV Ratio at the tumor level increased AUC to 0.85 (p\u2009=\u20090.016).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>FDG uptake increased in esophagus during-RT and this increase may predict radiation esphagitis during later course of treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1748-717x-9-37","type":"journal-article","created":{"date-parts":[[2014,1,27]],"date-time":"2014-01-27T14:02:16Z","timestamp":1390831336000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy"],"prefix":"10.1186","volume":"9","author":[{"given":"Shuanghu Tiger","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard KJ","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lujun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall K","family":"Ten Haken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milton","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemp B","family":"Cease","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Ming Spring","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,27]]},"reference":[{"key":"1218_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/00000421-198902000-00008","volume":"12","author":"F Mascarenhas","year":"1989","unstructured":"Mascarenhas F, et al.: Acute secondary effects in the esophagus in patients undergoing radiotherapy for carcinoma of the lung. Am J Clin Oncol 1989, 12: 34-40. 10.1097\/00000421-198902000-00008","journal-title":"Am J Clin Oncol"},{"key":"1218_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cllc.2011.03.026","volume":"12","author":"M Werner-Wasik","year":"2011","unstructured":"Werner-Wasik M, et al.: Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the radiation therapy oncology group (rtog) database. Clin Lung Cancer 2011, 12: 245-251. 10.1016\/j.cllc.2011.03.026","journal-title":"Clin Lung Cancer"},{"key":"1218_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0360-3016(93)90371-2","volume":"27","author":"JD Cox","year":"1993","unstructured":"Cox JD, et al.: Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 radiation therapy oncology group (rtog) trials. Int J Radiat Oncol Biol Phys 1993, 27: 493-498. 10.1016\/0360-3016(93)90371-2","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1218_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.canrad.2012.07.180","volume":"16","author":"T Challand","year":"2012","unstructured":"Challand T, et al.: Esophageal toxicity of radiation therapy: clinical risk factors and management. Cancer Radiother 2012, 16: 364-371. 10.1016\/j.canrad.2012.07.180","journal-title":"Cancer Radiother"},{"key":"1218_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0360-3016(99)00163-7","volume":"45","author":"PD Maguire","year":"1999","unstructured":"Maguire PD, et al.: Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys 1999, 45: 97-103. 10.1016\/S0360-3016(99)00163-7","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1218_CR6","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.ijrobp.2005.04.004","volume":"62","author":"K Takeda","year":"2005","unstructured":"Takeda K, et al.: Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2005, 62: 626-629. 10.1016\/j.ijrobp.2005.04.004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1218_CR7","first-page":"21","volume":"21","author":"A Ozgen","year":"2012","unstructured":"Ozgen A, Hayran M, Kahraman F: Mean esophageal radiation dose is predictive of the grade of acute esophagitis in lung cancer patients treated with concurrent radiotherapy and chemotherapy. J Radiat Res 2012, 21: 21.","journal-title":"J Radiat Res"},{"key":"1218_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0360-3016(02)03937-8","volume":"55","author":"AK Singh","year":"2003","unstructured":"Singh AK, Lockett MA, Bradley JD: Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2003, 55: 337-341. 10.1016\/S0360-3016(02)03937-8","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1218_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0001-2998(98)80038-X","volume":"28","author":"SM Bakheet","year":"1998","unstructured":"Bakheet SM, Powe J: Benign causes of 18-fdg uptake on whole body imaging. Semin Nucl Med 1998, 28: 352-358. 10.1016\/S0001-2998(98)80038-X","journal-title":"Semin Nucl Med"},{"key":"1218_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/00000658-200103000-00002","volume":"233","author":"BL Brucher","year":"2001","unstructured":"Brucher BL, et al.: Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg 2001, 233: 300-309. 10.1097\/00000658-200103000-00002","journal-title":"Ann Surg"},{"key":"1218_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/annonc\/mdf081","volume":"13","author":"P Flamen","year":"2002","unstructured":"Flamen P, et al.: Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol 2002, 13: 361-368. 10.1093\/annonc\/mdf081","journal-title":"Ann Oncol"},{"key":"1218_CR12","first-page":"1653","volume":"35","author":"SM Larson","year":"1994","unstructured":"Larson SM: Cancer or inflammation? a holy grail for nuclear medicine. J Nucl Med 1994, 35: 1653-1655.","journal-title":"J Nucl Med"},{"key":"1218_CR13","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.ijrobp.2005.03.033","volume":"63","author":"SY Song","year":"2005","unstructured":"Song SY, et al.: Fdg-pet in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer. Int J Radiat Oncol Biol Phys 2005, 63: 1053-1059. 10.1016\/j.ijrobp.2005.03.033","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1218_CR14","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1200\/JCO.2004.07.122","volume":"22","author":"HA Wieder","year":"2004","unstructured":"Wieder HA, et al.: Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 2004, 22: 900-908. 10.1200\/JCO.2004.07.122","journal-title":"J Clin Oncol"},{"key":"1218_CR15","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1200\/JCO.2006.10.3747","volume":"25","author":"FM Kong","year":"2007","unstructured":"Kong FM, et al.: A pilot study of [18f]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer. J Clin Oncol 2007, 25: 3116-3123. 10.1200\/JCO.2006.10.3747","journal-title":"J Clin Oncol"},{"key":"1218_CR16","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/00003072-199912000-00026","volume":"24","author":"SM Bakheet","year":"1999","unstructured":"Bakheet SM, et al.: F-18 fdg uptake in benign esophageal disease. Clin Nucl Med 1999, 24: 995-997. 10.1097\/00003072-199912000-00026","journal-title":"Clin Nucl Med"},{"key":"1218_CR17","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/01.rlu.0000090936.30974.e2","volume":"28","author":"P Bhargava","year":"2003","unstructured":"Bhargava P, et al.: Radiation-induced esophagitis on fdg pet imaging. Clin Nucl Med 2003, 28: 849-850. 10.1097\/01.rlu.0000090936.30974.e2","journal-title":"Clin Nucl Med"},{"key":"1218_CR18","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.ejso.2004.03.007","volume":"30","author":"I Brink","year":"2004","unstructured":"Brink I, et al.: Effects of neoadjuvant radio-chemotherapy on 18f-fdg-pet in esophageal carcinoma. Eur J Surg Oncol 2004, 30: 544-550. 10.1016\/j.ejso.2004.03.007","journal-title":"Eur J Surg Oncol"},{"key":"1218_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.radonc.2012.09.024","volume":"106","author":"J Nijkamp","year":"2013","unstructured":"Nijkamp J, et al.: Relating acute esophagitis to radiotherapy dose using fdg-pet in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer. Radiother Oncol 2013, 106: 118-123. 10.1016\/j.radonc.2012.09.024","journal-title":"Radiother Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-9-37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T11:51:51Z","timestamp":1630583511000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-9-37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,27]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1218"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-9-37","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,27]]},"assertion":[{"value":"21 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"37"}}